News


Nasdaq Stockholm Welcomes SenzaGen to First North

Thursday , 21 September 2017

 

Stockholm, September 21, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in SenzaGen AB’s shares (short name: SENZA) commenced today on Nasdaq First North in Stockholm. SenzaGen belongs to the health care sector and is the 76th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.

Estab...

READ MORE...


Lipocine Announces Motions Decision by USPTO in Interference Against Clarus

Thursday , 21 September 2017

 

SALT LAKE CITY , Sept. 21, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (NASDAQ:LPCN), a...

READ MORE...


Oxygen Concentrators and Cylinders Market worth over $4.5 billion by 2024: Global Market Insights, I

Thursday , 21 September 2017

 

Oxygen Concentrators and Cylinders Market By Product (Portable, Fixed), By Application (Healthcare, Pharmaceutical & Biotechnology, Manufacturing, Aerospace & Automotive, Others), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Global Forecast (2017 – 2024)

Ocean View, Delaware, Sept. ...

READ MORE...


Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Co

Thursday , 21 September 2017

 

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

Presentation with live webcast on Wednesday, September 27 at 1:00 p.m. ET

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- READ MORE...


Supplementary proposals of the Nomination Committee for the 2017 Annual General Meeting

Thursday , 21 September 2017

 

Uppsala, Sweden, 2017-09-21 08:15 CEST (GLOBE NEWSWIRE) -- For the AGM on September 25, 2017, the Board of Oasmia Pharmaceutical AB has been informed by the company's Nomination Committee of the following.

The Nomination Committee proposes that the Board to be composed of five directors elected at the AGM, with no alternates, for the period ...

READ MORE...


Zai Lab Limited Announces Pricing of U.S. Initial Public Offering of ADSs

Wednesday , 20 September 2017

 

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces the pricing of its U.S. initial public offering of American depositary shares (“ADSs”) (the “IPO”), raising gross proceeds of approximately US$150.0 million.

8,333,333 ADSs were sold in the IPO at a price of US$18.00 per ADS. Each ADS represents one ord...

READ MORE...


Namaste Announces Product Acquisition Agreement With Aphria Inc.

Wednesday , 20 September 2017

 

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

VANCOUVER, British Columbia, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:

READ MORE...


Cancer Genetics, Inc. Announces 25th Contract Win to Provide Testing & Diagnostic Services for Com

Wednesday , 20 September 2017

 

  • Nearly half of the 50+ Immuno-Oncology Clinical Trials that CGI is supporting are combination trials involving multiple oncology drugs.
  • CGI expects enrollment of over 4,500 patients into these combination Immuno-Oncology trials with leading pharma and biotech companies globally.

RUTHERFORD, N.J. and LOS ANGELES, Sept. 2...

READ MORE...


Identiv and Chronicled Partner to Present NFC-Enabled Temperature Logger Solution at 15th Annual G

Wednesday , 20 September 2017

 

FREMONT, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Identiv, Inc.  (NASDAQ:INVE) t...

READ MORE...


Antares Pharma to Present at the Ladenburg Thalmann 2017 Healthcare Conferen

Wednesday , 20 September 2017

 

EWING, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017 at 1:00 p.m. Eastern Time....

READ MORE...


Featured Employers

© 2017 Jobsinpharma - 4ward Technologies Ltd All rights reserved.